These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9383811)

  • 1. CNS sequelae in Langerhans cell histiocytosis: progressive spinocerebellar degeneration as a late manifestation of the disease.
    Cervera A; Madero L; García Peñas JJ; Díaz MA; Gutiérrez-Solana LG; Benito A; Ruiz-Falcó ML; Villa M
    Pediatr Hematol Oncol; 1997; 14(6):577-84. PubMed ID: 9383811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive spinocerebellar degeneration "plus" associated with Langerhans cell histiocytosis: a new paraneoplastic syndrome?
    Goldberg-Stern H; Weitz R; Zaizov R; Gornish M; Gadoth N
    J Neurol Neurosurg Psychiatry; 1995 Feb; 58(2):180-3. PubMed ID: 7876848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late outcomes in children with Langerhans cell histiocytosis.
    Chow TW; Leung WK; Cheng FWT; Kumta SM; Chu WCW; Lee V; Shing MMK; Li CK
    Arch Dis Child; 2017 Sep; 102(9):830-835. PubMed ID: 28442470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Central diabetes insipidus in adult patients--the first sign of Langerhans cell histiocytosis and Erdheim-Chester disease. Three case studies and literature review].
    Adam Z; Balsíková K; Krejcí M; Pour L; Stĕpánková S; Svacina P; Hermanová M; Vanícek J; Krupa P; Stanícek J; Koukalová R; Neubauer J; Krivanová A; Mayer J; Hájek R
    Vnitr Lek; 2010 Feb; 56(2):138-48. PubMed ID: 20329585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central nervous system disease associated with Langerhans' cell histiocytosis.
    Grois N; Barkovich AJ; Rosenau W; Ablin AR
    Am J Pediatr Hematol Oncol; 1993 May; 15(2):245-54. PubMed ID: 8498649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [MR-documented remission of pituitary stalk infiltration in patients with Langerhans cell histiocytosis following treatment with 2-chlorodeoxyadenosine].
    Vanícek J; Adam Z; Balsíková K; Krejcí M; Pour L; Szturz P; Zahradová L; Hájek R; Koukalová R; Rehák Z; Král Z; Mayer J
    Vnitr Lek; 2011 Oct; 57(10):871-5. PubMed ID: 22097697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco.
    Willis B; Ablin A; Weinberg V; Zoger S; Wara WM; Matthay KK
    J Clin Oncol; 1996 Jul; 14(7):2073-82. PubMed ID: 8683239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paediatric Langerhans Cell Histiocytosis Disease: Long-Term Sequelae in the Hypothalamic Endocrine System.
    Vaiani E; Felizzia G; Lubieniecki F; Braier J; Belgorosky A
    Horm Res Paediatr; 2021; 94(1-2):9-17. PubMed ID: 34167121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypopituitarism in langerhans cell histiocytosis: seven cases and literature review.
    Modan-Moses D; Weintraub M; Meyerovitch J; Segal-Lieberman G; Bielora B
    J Endocrinol Invest; 2001 Sep; 24(8):612-7. PubMed ID: 11686544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High dose immunoglobulin (IVIG) may reduce the incidence of Langerhans cell histiocytosis (LCH)-associated central nervous system involvement.
    Imashuku S
    CNS Neurol Disord Drug Targets; 2009 Nov; 8(5):380-6. PubMed ID: 19702569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for the Prevention of Central Nervous System Complications in Patients with Langerhans Cell Histiocytosis: The Problem of Neurodegenerative Syndrome.
    Imashuku S; Arceci RJ
    Hematol Oncol Clin North Am; 2015 Oct; 29(5):875-93. PubMed ID: 26461148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment.
    Kaltsas GA; Powles TB; Evanson J; Plowman PN; Drinkwater JE; Jenkins PJ; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1370-6. PubMed ID: 10770168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central diabetes insipidus as the inaugural manifestation of Langerhans cell histiocytosis: natural history and medical evaluation of 26 children and adolescents.
    Marchand I; Barkaoui MA; Garel C; Polak M; Donadieu J;
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1352-60. PubMed ID: 21752883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary stalk thickening with diabetes insipidus preceding typical manifestations of Langerhans cell histiocytosis in children.
    Schmitt S; Wichmann W; Martin E; Zachmann M; Schoenle EJ
    Eur J Pediatr; 1993 May; 152(5):399-401. PubMed ID: 8319704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuroimaging of Langerhans cell histiocytosis in the central nervous system of children].
    De La Hoz Polo M; Rebollo Polo M; Fons Estupiña C; Muchart López J; Cruz Martinez O
    Radiologia; 2015; 57(2):123-30. PubMed ID: 24837565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
    Morimoto A; Shioda Y; Imamura T; Kudo K; Kitoh T; Kawaguchi H; Goto H; Kosaka Y; Tsunematsu Y; Imashuku S;
    Int J Hematol; 2018 Aug; 108(2):192-198. PubMed ID: 29594922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebellar ataxia in pediatric patients with Langerhans cell histiocytosis.
    Imashuku S; Ishida S; Koike K; Ichikawa M; Minato T; Suzuki Y; Kobayashi R; Morimoto A;
    J Pediatr Hematol Oncol; 2004 Nov; 26(11):735-9. PubMed ID: 15543008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine and metabolic assessment in adults with Langerhans cell histiocytosis.
    Montefusco L; Harari S; Elia D; Rossi A; Specchia C; Torre O; Adda G; Arosio M
    Eur J Intern Med; 2018 May; 51():61-67. PubMed ID: 29198444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of Langerhans cell histiocytosis with thyroid involvement.
    Baş VN; Cetinkaya S; Apaydin S; Bozkurt C; Cavuşoğlu YH; Aycan Z
    J Pediatr Endocrinol Metab; 2011; 24(11-12):1059-61. PubMed ID: 22308866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system-related permanent consequences in patients with Langerhans cell histiocytosis.
    Mittheisz E; Seidl R; Prayer D; Waldenmair M; Neophytou B; Pötschger U; Minkov M; Steiner M; Prosch H; Wnorowski M; Gadner H; Grois N
    Pediatr Blood Cancer; 2007 Jan; 48(1):50-6. PubMed ID: 16470521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.